Tesla, Walt Disney Fall Premarket; AstraZeneca Climbs By Investing.com
By Peter Nurse
Investing.com — Stocks in focus in premarket trade on Monday, September 20th. Refresh to see the most recent updates.
Tesla (NASDAQ:) stock fell 2.4% after National Transportation Safety Board chief Jennifer Homendy criticised the company’s rollout of driver-assistance software in an interview with the Wall Street Journal, saying the electric car maker needed first to address safety deficiencies in its full self-driving technology.
Colgate-Palmolive (NYSE:) stock rose 0.1%, outperforming the wider market, after Deutsche Bank (DE:) upgraded its stance on the consumer products maker to ‘buy’ from ‘hold’, saying the market has missed the company’s turnaround.
Pfizer (NYSE:) stock fell 1.4% after the drug maker said its Covid-19 vaccine induced a robust immune response in 5 to 11 year olds, and it plans to seek authorization for use in the United States, Europe and elsewhere as soon as possible.
CVS Health (NYSE:) stock fell 1.5%, outperforming the wider market after announcing it would fill as many as 25,000 clinical and retail jobs ahead of the flu season and as the United States prepares to administer booster Covid-19 vaccine shots.
AstraZeneca (NASDAQ:) ADRs rose 1.3% after the U.K.-based drugmaker announced that its breast cancer drug Enhertu showed positive results in a late-stage trial.
Netflix (NASDAQ:) stock fell 0.9%, outperforming Walt Disney (NYSE:), down 2%, following the 73rd Emmy Awards, with the streaming service winning more Emmys than any other rival, network or platform, for the first time ever.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.